Drug intelligence / Profile preview

prednisolone

Development stage
Approved
Lead developer
Bayer HealthCare Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular, Ophthalmic
01

Overview

Prednisolone is a synthetic glucocorticoid corticosteroid used to treat a wide range of inflammatory and autoimmune conditions such as arthritis, lupus, psoriasis, ulcerative colitis, allergic disorders, blood disorders, skin diseases, certain cancers (including leukemia and lymphoma), and to prevent organ rejection after transplantation. It works primarily by mimicking the effects of cortisol—a hormone produced by the adrenal glands—thereby reducing inflammation and suppressing immune system activity. Mechanistically, prednisolone binds to glucocorticoid receptors in cells; this complex then translocates into the nucleus where it alters gene expression to inhibit proinflammatory cytokine production and reduce migration of immune cells like leukocytes[1][2][3][4][5]. Prednisolone was first approved for medical use in 1955[2][5].

Brand names
Flo-PredMillipredOrapredPediapredVeripred 20Veripred20Veripred-20
Other names
Prednisolone 17-valerate 21-acetatePrednisolone17-valerate 21-acetatePrednisolone-17-valerate 21-acetatePVAPrednisolone valerate-acetate
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call